GSK soothes investors by settling first Zantac cancer lawsuit due for US trial
(This June 23 story has been corrected to say analysts had suggested cases in California, not only the Goetz case, would have cost GSK ‘low hundreds of millions’ of dollars to settle, in paragraph 13) By Natalie Grover and Eva Mathews (Reuters) – GSK agreed to settle a U.S. lawsuit alleging its discontinued heartburn drug …
GSK soothes investors by settling first Zantac cancer lawsuit due for US trial Read More »









